Investing.com - Ipsen reported on Friday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Ipsen announced earnings per share of €7.76 on revenue of €791M. Analysts polled by Investing.com anticipated EPS of €3.39 on revenue of €768.02M.
Ipsen shares are up 19% from the beginning of the year, still down 1.13% from its 52 week high of €97.58 set on February 11. They are outperforming the STOXX 600 which is down 3.74% from the start of the year.
Ipsen follows other major Healthcare sector earnings this month
Ipsen's report follows an earnings beat by Sanofi on February 4, who reported EPS of €1.38 on revenue of €9.99B, compared to forecasts EPS of €1.34 on revenue of €10.31B.
Sartorius Stedim had matched expectations on January 27 with fourth quarter EPS of €1.82 on revenue of €778.15M, compared to forecast for EPS of €1.82 on revenue of €780.87M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar